Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656941 · ClinicalTrials.gov registry record
Genetic Determinants of Congenital Heart Disease Outcomes
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 250
- Enrollment target
NCT01656941 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 250 participants.
The verdict
NCT01656941 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the role of genetic variation in the oxidative stress response on critical perioperative and short-term outcomes after neonatal heart surgery. The goals will be to determine 1) if the oxidative stress pathway is an important one for therapeutic intervention in neonates with severe congenital heart defects and 2) if variants in the oxidative response pathway can be used to identify patients at increased risk for adverse outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-03-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01656941
The ClinicalTrials.gov registry entry for NCT01656941 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01656941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01656941 about?
NCT01656941 is a clinical study titled "Genetic Determinants of Congenital Heart Disease Outcomes". The purpose of this study is to examine the role of genetic variation in the oxidative stress response on critical perioperative and short-term outcomes after neonatal heart surgery. The goals will be to determine 1) if the oxidative stress pathway is an important one for therapeutic intervention in...
What is the current status of trial NCT01656941?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2011-03. Estimated completion is 2017-03-16.
Who is sponsoring clinical trial NCT01656941?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.